curasan entered into an exclusive agreement whereby Implantcast will distribute CERASORB pure-phase beta-tricalcium phosphate bone regeneration products in Austria, Germany and Switzerland. Discussions are underway to extend the agreement to other countries in Implantcast’s network.
Implantcast’s products include primary, revision and tumor endoprostheses for hip, knee, extremities and thumb, as well as patient-specific implants.
curasan, based in Germany, has undertaken a variety of activities to grow its global reach. In 2016, the company announced its intent to target sales and marketing growth in the U.S. and China. The company entered the U.S. bone graft substitute market in 2Q17 with CERASORB Ortho Foam bone graft, and earlier this month, entered into a private label distribution agreement with Xtant Medical to distribute Matriform synthetic scaffolds in North America.
Sources: curasan AG; ORTHOWORLD Inc.
curasan entered into an exclusive agreement whereby Implantcast will distribute CERASORB pure-phase beta-tricalcium phosphate bone regeneration products in Austria, Germany and Switzerland. Discussions are underway to extend the agreement to other countries in Implantcast's network.
Implantcast's products include primary, revision and tumor...
curasan entered into an exclusive agreement whereby Implantcast will distribute CERASORB pure-phase beta-tricalcium phosphate bone regeneration products in Austria, Germany and Switzerland. Discussions are underway to extend the agreement to other countries in Implantcast’s network.
Implantcast’s products include primary, revision and tumor endoprostheses for hip, knee, extremities and thumb, as well as patient-specific implants.
curasan, based in Germany, has undertaken a variety of activities to grow its global reach. In 2016, the company announced its intent to target sales and marketing growth in the U.S. and China. The company entered the U.S. bone graft substitute market in 2Q17 with CERASORB Ortho Foam bone graft, and earlier this month, entered into a private label distribution agreement with Xtant Medical to distribute Matriform synthetic scaffolds in North America.
Sources: curasan AG; ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
